Improving management of psoriasis patients receiving biological treatment: A qualitative approach.

Findings come from one Danish outpatient clinic, so they may not transfer to other services or countries. Only 15 patients and 10 clinicians were interviewed, so it is a detailed snapshot, not a measure of how common these experiences are. The researcher observed consultations and was employed at the hospital, which could have influenced what patients and clinicians said or did. It reports experiences and themes, not treatment effects or patient outcomes, so it cannot show that changing consultations improves psoriasis control. The study focused on patients receiving biological treatment and clinicians in that clinic; it does not describe other psoriasis treatments or broader workforce issues.

One author received an unrestricted Novartis grant covering four months of salary, with no reported role in study design, data collection, analysis, publication decisions or manuscript preparation. Another author reported research, speaking or consulting support from a long list of named companies and organizations, and is founder and majority owner of DrScore.com and part owner of Causa Research. Funding came from the University of Southern Denmark, Robert Wehnerts og Kirsten Wehnerts Fond, Odense University Hospital and Novartis.

Do not read this as proof that fewer visits or a different consultation format works. It describes patients’ and clinicians’ experiences only, and the study did not test any change to care.